ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Supansa Nilubol, Worawit Kitisakronnakorn, Pimjai Naigovit
This study reported two cases of Thai cancer patients, including a 36-year-old female with thyroid cancer of more than 5 years and a 64-year-old male with lung and colon cancers of more than 10 years. The written informed consent was provided for autologous n…
Chunhui Hu, Yuqian Wu, Jiaojiao Tong, Ying Zhang, Dianshui Sun
Background: Clinicopathological and biological features are associated with neck lymph node metastasis (LNM) of hypopharyngeal squamous cell carcinoma (HSCC). However, there is no complete nomogram combining multiple factors that can be used to accurately pre…
Abdoulatif Amadou, Pihou Gbande, Ablavi Adani-Ifè, Massaga Dagbe, Icael Youaleu, Lantam Sonhaye, Lama Kedigoma Agoda-Koussema, Komlanvi Adjenou
Cancer is common in our setting and represents a real public health concern in sub-Saharan Africa. This work aimed to assess the role of computed tomography in the follow-up of patients treated for cancer in Togo. This was a retrospective descriptive study ca…
Emad Mohsen Barsoum, Fiby Samir Boules, May Gamal Ashour, Mohsen Samy Barsoum
Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51 - year - old male patient treated with pegylated IFN- α in a monthly schedule with low-dose prednisolone and achi…
Azza M. Adel
Background: Diabetes mellitus and breast cancer are both chronic diseases. Breast cancer in patients with diabetes is often diagnosed at an advanced stage and ha s worse prognosis. Aim of work: To investigate the clinicopathological factors, hormonal receptor…
Abdoulatif Amadou, Solim Nabede, Pihou Gbande, Massaga Dagbe, Lantam Sonhaye, Lama Kedigoma Agoda-Koussema, Komlanvi Adjenou
Breast cancer represents a real public health problem due to its increasing frequency, its seriousness and its psycho-social implications. The aims of this study were to determine the level of awareness of women on the performance of mammography in the diagno…
Emilly Silva e Silva, Gerlane Lima Oliveira, Ana Carolina Carneiro Cardoso, Isabella Melo Brito Ferreira, Marco Tulio Brazão-Silva, Douglas Magno Guimarães
Radiotherapy (RT) in the head and neck, despite coming from technological evolution, is challenged by the acute and late side effects of local irradiation, including permanent loss of saliva, osteoradionecrosis, dental caries induced by radiation and necrosis…
Maryam Zaouit, Sia Nioka Pierre Xavier, Hanan Rida, Hassan Jouhadi, Tarik Chekrine, Zineb Bouchbika, Nadia Benchekroun, Nezha Tawfiq, Souha Sahraoui, Abdellatif Benider
Introduction: Primary renal synovialosarcoma (SVS) is a rare and aggressive disease in which the metastatic potential is very high. Its diagnosis is based on morphological and molecular studies. No therapeutic consensus has yet been established for this histo…
Farhana Kalam, Shahana Pervin, K. M. Nazmul Islam Joy, Johirul Islam, Annekathryn Goodman
Introduction: This study evaluated the difference in operative and clinica l outc omes for patients with advanced ovarian cancer after primary debulking surgery (PDS) versus neoadjuvant chemotherapy (NACT) followed by interval debul king surgery (IDS) in Bang…
Aravindh Sivanandan Anand, Annie Joseph, Antony Stanley
Background: In India approximately 20% of the patients with breast cancer are triple receptor negative. Owing to the aggressive nature and shorter disease-free survival judicious follow up and identification of failure pattern will benefit the patient. Simila…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).